Infection following the implantation of a left ventricular assist device (LVAD) is a life-threatening complication with mortality rates ranging from 15% to 44%. Staphylococcus aureus and Staphylococcus epidermidis are the most frequently identified pathogensand are responsible for 60% of LVAD-related infections, local as well as systemic. In this report we describe the successful therapeutic management of a patient who received a Heart Mate II as "bridging-to-recovery", which was complicated by device infection that was managed without device explantation.

Endocarditis, Heart Mate II, Left ventricular assist device
Hellenic Journal of Cardiology
Department of Cardiology

Gogas, B.D, Parissis, J.T, Iliodromitis, E.K, Tsiodras, S, Radu, M, Paraskevaidis, I.A, … Yacoub, M.H. (2010). Left ventricular assist device vegetation: "Cure" without device explantation. Hellenic Journal of Cardiology, 51(6), 549–551. Retrieved from